Vancouver, British Columbia, Canada, January 2026 – Laura O’Connor has been appointed as Chief Human Resources Officer at Zymeworks Inc., where she will lead the company’s global people strategy as Zymeworks accelerates its oncology and autoimmune disease innovation pipeline.
In her immediate prior role at Zymeworks Inc., Laura O’Connor served as Vice President, Human Resources and DEI, where she strengthened talent strategy, diversity, equity and inclusion frameworks, and organizational capability building across the company’s expanding clinical and research teams.
Earlier, she was Head of Global Human Resources at Zymeworks Biopharmaceuticals Inc., playing a central role in scaling global HR operations and building leadership capability across research, clinical and corporate functions.
Before joining Zymeworks, she served as Director of Human Resources at Merz Pharma Canada and earlier at Ferring Pharmaceuticals, where she led comprehensive HR operations supporting rapidly growing biopharmaceutical portfolios in Canada.
About Zymeworks Inc.
Zymeworks Inc. is a clinical-stage biotechnology company advancing next-generation antibody therapeutics for cancer and autoimmune diseases. Its pipeline includes innovative antibody-drug conjugates, multispecific antibodies and its lead asset zanidatamab, aimed at addressing areas of high unmet medical need worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
